Mao-bing Chen
YOU?
Author Swipe
View article: Smoking behaviors, physical activities, pulmonary diseases and COVID-19 severity: A Mendelian randomization study
Smoking behaviors, physical activities, pulmonary diseases and COVID-19 severity: A Mendelian randomization study Open
Smoking behaviors, physical activities, and pulmonary diseases have been revealed to be associated with COVID-19 severity through observational research. The possible causative effect remains undetermined. To investigate this, we thus carr…
View article: Efficacy of probiotic adjuvant therapy for irritable bowel syndrome in children: A systematic review and meta-analysis
Efficacy of probiotic adjuvant therapy for irritable bowel syndrome in children: A systematic review and meta-analysis Open
Objective Irritable bowel syndrome (IBS) affects children’s quality of life and learning. The purpose of this research was to systematically evaluate the efficacy of probiotic adjuvant therapy for IBS in children. Methods The Web of Scienc…
View article: Effect of SGLT inhibitors on weight and lipid metabolism at 24 weeks of treatment in patients with diabetes mellitus
Effect of SGLT inhibitors on weight and lipid metabolism at 24 weeks of treatment in patients with diabetes mellitus Open
Background: The goals of improving quality of life and increasing longevity are receiving growing amounts of attention. Body weight and lipid metabolism are closely related to various complications of diabetes. The aim of this study was to…
View article: Effect of sodium-dependent glucose transporter inhibitors on glycated hemoglobin A1c after 24 weeks in patients with diabetes mellitus
Effect of sodium-dependent glucose transporter inhibitors on glycated hemoglobin A1c after 24 weeks in patients with diabetes mellitus Open
Background: To evaluate dapagliflozin, canagliflozin, empagliflozin, ertugliflozin, and sotagliflozin according to their effect on the glycated hemoglobin A1c (HbA1c) level in patients with type 2 diabetes mellitus. Methods: The Web of Sci…
View article: Efficacy and safety of sotagliflozin adjuvant therapy for type 1 diabetes mellitus
Efficacy and safety of sotagliflozin adjuvant therapy for type 1 diabetes mellitus Open
Background: To systematically evaluate the efficacy and safety of sotagliflozin (SOTA) adjuvant therapy for type 1 diabetes mellitus (T1DM). Methods: Through April 2019, the Web of Science, PubMed, Cochrane Library, Embase, and China Natio…
View article: The efficacy of masks for influenza-like illness in the community
The efficacy of masks for influenza-like illness in the community Open
Background: During the COVID-19 period, there was a huge gap in the understanding of masks between east and west. At the same time, the mechanism of the mask and the effect after use, also appeared differences. The Objective of this Meta-a…
View article: Comparative efficacy of the front-line anti-HBV drugs in nucleos(t)ide analogue-naive chronic hepatitis B
Comparative efficacy of the front-line anti-HBV drugs in nucleos(t)ide analogue-naive chronic hepatitis B Open
Background: During the COVID-19 period, there was a huge gap in the understanding of masks between east and west. At the same time, the mechanism of the mask and the effect after use, also appeared differences. The Objective of this Meta-a…
View article: Comparative efficacy of the front-line anti-HBV drugs in nucleos(t)ide analogue-naive chronic hepatitis B, A protocol for systematic review and network meta-analysis
Comparative efficacy of the front-line anti-HBV drugs in nucleos(t)ide analogue-naive chronic hepatitis B, A protocol for systematic review and network meta-analysis Open
e v i e w q u e s t i o n : To systematically evaluate the efficacy and safety of TAF, TDF and ETV in nucleos(t)ide analogue-naive Chronic Hepatitis B. Compare the efficacy of several drugs by sorting them.Condition being studied: Chronic …
View article: Comparative efficacy of tenofovir and entecavir in nucleos(t)ide analogue-naive chronic hepatitis B: A systematic review and meta-analysis
Comparative efficacy of tenofovir and entecavir in nucleos(t)ide analogue-naive chronic hepatitis B: A systematic review and meta-analysis Open
Tenofovir and entecavir were equally effective in the treatment of patients with nucleos(t)ide analogue-naive chronic hepatitis B. In addition, TDF has an advantage in the incidence of hepatocellular carcinoma. Additional RCTs and a large-…
View article: Effectiveness and safety of hypotensive resuscitation in traumatic hemorrhagic shock
Effectiveness and safety of hypotensive resuscitation in traumatic hemorrhagic shock Open
Background: Hypotensive resuscitation is an old study. But its benefits and losses are still controversial. In clinic, the method of fluid resuscitation needs more reliable experimental evidence. This study's objective is to systematically…
View article: A comparison of sotagliflozin therapy for diabetes mellitus between week 24 with week 52
A comparison of sotagliflozin therapy for diabetes mellitus between week 24 with week 52 Open
Background: According to the centers for disease control and prevention, 14% of American adults have diabetes – 10% know it, and more than 4% go undiagnosed. Sotagliflozin is a new type of diabetes drug This study is to compare the efficac…
View article: Effectiveness of tenofovir and entecavir in nucleos(t)ide analogue-naive chronic hepatitis B
Effectiveness of tenofovir and entecavir in nucleos(t)ide analogue-naive chronic hepatitis B Open
Background: Chronic hepatitis b (CHB) is a serious problem worldwide. Tenofovir disoproxil fumarate (TDF) and entecavir (ETV) both are first-line drugs for CHB, but there is debate about which is more appropriate in nucleos(t)ide analogue-…
View article: Effectiveness and safety of sotagliflozin adjuvant therapy for type 1 diabetes mellitus
Effectiveness and safety of sotagliflozin adjuvant therapy for type 1 diabetes mellitus Open
Background: Type 1 Diabetes Mellitus (T1DM) has long required insulin treatment. Sotagliflflozin (SOTA), as a dual SGLT-1/2 inhibitor, has the potential to be the first oral antidiabetic drug (OAD) to be approved for T1DM in the US market.…